133 related articles for article (PubMed ID: 12608936)
1. The effect of growth hormone (GH) replacement therapy in adult patients with type 1 diabetes mellitus and GH deficiency.
Christ ER; Simpson HL; Breen L; Sönksen PH; Russell-Jones DL; Kohner EM
Clin Endocrinol (Oxf); 2003 Mar; 58(3):309-15. PubMed ID: 12608936
[TBL] [Abstract][Full Text] [Related]
2. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
[TBL] [Abstract][Full Text] [Related]
3. Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy.
Hayes FJ; Fiad TM; McKenna TJ
Metabolism; 1999 Mar; 48(3):308-13. PubMed ID: 10094105
[TBL] [Abstract][Full Text] [Related]
4. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
[TBL] [Abstract][Full Text] [Related]
5. A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.
Bülow B; Erfurth EM
Clin Endocrinol (Oxf); 1999 Jan; 50(1):45-55. PubMed ID: 10341855
[TBL] [Abstract][Full Text] [Related]
6. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study.
Christ ER; Cummings MH; Lumb PJ; Crook MA; Sönksen PH; Russell-Jones DL
Clin Endocrinol (Oxf); 1999 Aug; 51(2):173-9. PubMed ID: 10468987
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity.
Christ ER; Chowienczyk PJ; Sönksen PH; Russel-Jones DL
Clin Endocrinol (Oxf); 1999 Jul; 51(1):21-5. PubMed ID: 10468961
[TBL] [Abstract][Full Text] [Related]
9. Influences on quality of life in GH deficient adults and their effect on response to treatment.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
[TBL] [Abstract][Full Text] [Related]
10. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Shalet SM
Clin Endocrinol (Oxf); 1999 Jun; 50(6):749-57. PubMed ID: 10468947
[TBL] [Abstract][Full Text] [Related]
11. Increase in haemoglobin concentrations in growth hormone deficient adults during human recombinant growth hormone replacement therapy.
Ten Have SM; van der Lely AJ; Lamberts SW
Clin Endocrinol (Oxf); 1997 Nov; 47(5):565-70. PubMed ID: 9425396
[TBL] [Abstract][Full Text] [Related]
12. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.
Wallymahmed ME; Foy P; Shaw D; Hutcheon R; Edwards RH; MacFarlane IA
Clin Endocrinol (Oxf); 1997 Oct; 47(4):439-46. PubMed ID: 9404442
[TBL] [Abstract][Full Text] [Related]
13. Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment.
Halldin MU; Brismar K; Tuvemo T; Gustafsson J
Clin Endocrinol (Oxf); 2002 Dec; 57(6):735-43. PubMed ID: 12460323
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
15. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
McConnell EM; Atkinson AB; Ennis C; Hadden DR; McCance DR; Sheridan B; Bell PM
J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
[TBL] [Abstract][Full Text] [Related]
16. Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.
Herrmann BL; Berg C; Vogel E; Nowak T; Renzing-Koehler K; Mann K; Saller B
Horm Metab Res; 2004 Jan; 36(1):54-61. PubMed ID: 14983408
[TBL] [Abstract][Full Text] [Related]
17. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.
Beshyah SA; Freemantle C; Shahi M; Anyaoku V; Merson S; Lynch S; Skinner E; Sharp P; Foale R; Johnston DG
Clin Endocrinol (Oxf); 1995 Jan; 42(1):73-84. PubMed ID: 7889635
[TBL] [Abstract][Full Text] [Related]
18. The relationship between overnight GH levels and insulin concentrations in adolescents with insulin-dependent diabetes mellitus (IDDM) and the impact of recombinant human insulin-like growth factor I (rhIGF-I).
Cheetham TD; Connors M; Clayton K; Watts A; Dunger DB
Clin Endocrinol (Oxf); 1997 Apr; 46(4):415-24. PubMed ID: 9196603
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion.
Shishko PI; Dreval AV; Abugova IA; Zajarny IU; Goncharov VC
Diabetes Res Clin Pract; 1994 Aug; 25(1):1-12. PubMed ID: 7530621
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing the desire for long-term growth hormone replacement in adults.
Holmes SJ; Shalet SM
Clin Endocrinol (Oxf); 1995 Aug; 43(2):151-7. PubMed ID: 7554309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]